Neurophysiological Assessment Aids in Identifying Back Injury

Share this content:
Neurophysiological Assessment Aids in Identifying Back Injury
Neurophysiological Assessment Aids in Identifying Back Injury

(HealthDay News) -- For patients with lumbosacral disc herniation, neurophysiological tests together with neuroimaging and clinical examination allow for accurate preoperative assessment of injury, according to a study published in the Oct. 1 issue of Spine.

Magdalena Wojtysiak, M.D., Ph.D., from the Poznán University of Medical Sciences in Poland, and colleagues conducted a comparative analysis of preoperative and postoperative electromyography, electroneurography, F-waves, H-reflex, and motor evoked potentials (MEP) for 23 patients with confirmed disc-root conflict at lumbosacral spine. The patients also underwent clinical assessment, including examination of sensory perception for L5 to S1 dermatomes, muscle strength, deep tendon reflexes, pain intensity, and straight leg-raising test.

The researchers found that for evaluation of L5 to S1 roots injury, the sensitivity of electromyography at rest was 22 to 63 percent and of MEP examination was 31 to 56 percent; the corresponding specificities were 71 to 83 percent and 57 to 86 percent. For evaluation of S1 root injury, H-reflex sensitivity and specificity were 56 and 67 percent, respectively. For L5 and S1 root levels, there were significant improvements of root latency parameter in postoperative versus preoperative MEP studies.

"The analysis of the results from neurophysiological tests together with neuroimaging and clinical examination allow for a precise preoperative indication of the lumbosacral roots injury and accurate postoperative evaluation of patients experiencing sciatica," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »